Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS302 in Pediatric Cataract Surgery
NCT02132312Phase 3Completed
- Sponsor
- Omeros Corporation
- Start
- Jul 2014
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
A Phase 3 trial of phenylephrine + ketorolac in congenital cataract, sponsored by Omeros Corporation. Started Jul 2014; status: completed.
02
Drugs
phenylephrine + ketorolac
03
Conditions
congenital cataract
Beyond the preview
Go deeper on NCT02132312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132312.